DNA repair pathways in human multiple myeloma: role in oncogenesis and potential targets for treatment.
about
NKG2D and DNAM-1 Ligands: Molecular Targets for NK Cell-Mediated Immunotherapeutic Intervention in Multiple MyelomaChromatin structure, transcriptional activity and DNA repair efficiency affect the outcome of chemotherapy in multiple myeloma.YSY01A, a Novel Proteasome Inhibitor, Induces Cell Cycle Arrest on G2 Phase in MCF-7 Cells via ERα and PI3K/Akt Pathways.CD8 Memory Cells Develop Unique DNA Repair Mechanisms Favoring Productive DivisionEvidence for a role of the histone deacetylase SIRT6 in DNA damage response of multiple myeloma cellsNucleotide excision repair is a potential therapeutic target in multiple myeloma.Synergistic suppressive effect of PARP-1 inhibitor PJ34 and HDAC inhibitor SAHA on proliferation of liver cancer cells.Regulation of STAT3 and NF-κB activations by S-nitrosylation in multiple myeloma.RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myelomaVTD-melphalan is well tolerated and results in very high rates of stringent CR and MRD-negative status in multiple myeloma.Heme oxygenase-1 nuclear translocation regulates bortezomibinduced cytotoxicity and mediates genomic instability in myeloma cells.HIF-1α and rapamycin act as gerosuppressant in multiple myeloma cells upon genotoxic stress.Recurrent alterations of the WW domain containing oxidoreductase gene spanning the common fragile site FRA16D in multiple myeloma and monoclonal gammopathy of undetermined significance.The role of DNA damage and repair in decitabine-mediated apoptosis in multiple myeloma.MMSET/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents.Discovering proteasomal deubiquitinating enzyme inhibitors for cancer therapy: lessons from rational design, nature and old drug repositionHMGB1 knockdown increases MM cell vulnerability by regulating autophagy and DNA damage repair
P2860
Q28080823-A62B8668-E738-4A34-86E6-53CBC13EDBBFQ34283680-F7EE8A81-6B37-4200-A96D-C8EF296F0972Q35148080-70172699-BA79-4B1F-AB35-3E1AA72599ECQ35815012-836D4723-7F9C-4C25-99EC-4AD566E695A8Q36651351-467AADAE-262B-4CA0-A87B-F8EC25A7198FQ38739689-9FB60E9B-456E-4F73-B1DC-ECA695892315Q38848047-AF5EC301-FAFE-4402-9412-56C9A84198FEQ38945383-2C22C2E5-85DF-4CEF-ADA6-54315088ADCFQ38967891-532AFD3E-11D1-490D-996E-1AEC1A1B4B63Q39103567-14969B90-C858-48B2-A5C9-913B00DF06D1Q39956732-0DD276DD-9B01-48B2-8BA7-D4D943092659Q41449149-2CF76F60-3707-458A-8335-96005BFBA7AEQ41701970-2AB42B95-BBF8-4AEB-BA3E-05ABDB689429Q42459032-25CE8C26-F5EF-4744-9C19-090001EB7C0FQ51358936-67258DC2-EBE9-4639-9A6E-380B04AA0B80Q57163862-B40A2583-831A-401F-BE6D-735F2D10366BQ58696530-27DEFFB6-BE2F-4FD9-9AF8-7157E63513FA
P2860
DNA repair pathways in human multiple myeloma: role in oncogenesis and potential targets for treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
DNA repair pathways in human m ...... tential targets for treatment.
@en
DNA repair pathways in human m ...... tential targets for treatment.
@nl
type
label
DNA repair pathways in human m ...... tential targets for treatment.
@en
DNA repair pathways in human m ...... tential targets for treatment.
@nl
prefLabel
DNA repair pathways in human m ...... tential targets for treatment.
@en
DNA repair pathways in human m ...... tential targets for treatment.
@nl
P2093
P2860
P356
P1433
P1476
DNA repair pathways in human m ...... tential targets for treatment.
@en
P2093
Alboukadel Kassambara
Angelos Constantinou
Bernard Klein
Claire Gourzones-Dmitriev
Jérôme Moreaux
Pascal Bourquard
Surinder Sahota
Thierry Rème
P2860
P304
P356
10.4161/CC.25951
P577
2013-08-09T00:00:00Z